206 related articles for article (PubMed ID: 24748925)
1. Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease.
Lopez LR; Guyer KE; Torre IG; Pitts KR; Matsuura E; Ames PR
World J Diabetes; 2014 Apr; 5(2):115-27. PubMed ID: 24748925
[TBL] [Abstract][Full Text] [Related]
2. Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus.
Ames PR; Batuca JR; Muncy IJ; De La Torre IG; Pascoe-Gonzales S; Guyer K; Matsuura E; Lopez LR
Thromb Res; 2012 Sep; 130(3):350-4. PubMed ID: 22521214
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of urinary 11-dehydro-thromboxane B
Vasudevan A; Tecson KM; Bennett-Firmin J; Bottiglieri T; Lopez LR; Peterson M; Sathyamoorthy M; Schiffmann R; Schussler JM; Swift C; Velasco CE; McCullough PA
Catheter Cardiovasc Interv; 2018 Oct; 92(4):653-658. PubMed ID: 29193683
[TBL] [Abstract][Full Text] [Related]
4. Urinary 11-Dehydro-Thromboxane B
McCullough PA; Vasudevan A; Sathyamoorthy M; Schussler JM; Velasco CE; Lopez LR; Swift C; Peterson M; Bennett-Firmin J; Schiffmann R; Bottiglieri T
Am J Cardiol; 2017 Apr; 119(7):972-977. PubMed ID: 28139223
[TBL] [Abstract][Full Text] [Related]
5. Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease.
Vasudevan A; Bottiglieri T; Tecson KM; Sathyamoorthy M; Schussler JM; Velasco CE; Lopez LR; Swift C; Peterson M; Bennett-Firmin J; Schiffmann R; McCullough PA
Coron Artery Dis; 2017 Jun; 28(4):287-293. PubMed ID: 28005558
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease].
Liu TF; Zhang JW; Chen XH; Feng XR; Bai ZS; Liu ML
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):920-4. PubMed ID: 26679651
[TBL] [Abstract][Full Text] [Related]
7. Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation.
Cao Y; Zhao F; Wang S; Li Y; Li S; Cui X
Clin Chim Acta; 2024 May; 558():119672. PubMed ID: 38621589
[TBL] [Abstract][Full Text] [Related]
8. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
[TBL] [Abstract][Full Text] [Related]
9. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty.
Ciabattoni G; Ujang S; Sritara P; Andreotti F; Davies G; Simonetti BM; Patrono C; Maseri A
J Am Coll Cardiol; 1993 May; 21(6):1377-81. PubMed ID: 8473644
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane biosynthesis and platelet function in type II diabetes mellitus.
Davì G; Catalano I; Averna M; Notarbartolo A; Strano A; Ciabattoni G; Patrono C
N Engl J Med; 1990 Jun; 322(25):1769-74. PubMed ID: 2345567
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of immediate-release and extended-release aspirin on basal and bradykinin-stimulated excretion of thromboxane and prostacyclin metabolites.
Gamboa JL; Devin JK; Ramirez CE; Yu C; Nian H; Lee RH; Brown NJ
Pharmacol Res Perspect; 2016 Apr; 4(2):e00221. PubMed ID: 27069632
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus.
Gurbel PA; Bliden KP; Chaudhary R; Patrick J; Liu F; Chen G; McLeod C; Tantry US
Am J Cardiol; 2016 Dec; 118(12):1941-1947. PubMed ID: 27769511
[TBL] [Abstract][Full Text] [Related]
15. Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin.
Montalescot G; Maclouf J; Drobinski G; Salloum J; Grosgogeat Y; Thomas D
J Am Coll Cardiol; 1994 Jul; 24(1):33-8. PubMed ID: 8006280
[TBL] [Abstract][Full Text] [Related]
16. Significance of urinary 11-dehydro-thromboxane B
Simeone P; Boccatonda A; Liani R; Santilli F
Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676
[TBL] [Abstract][Full Text] [Related]
17. In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies.
Vainio M; Mäenpää J; Riutta A; Ylitalo P; Ala-Fossi SL; Tuimala R
Acta Obstet Gynecol Scand; 1999 Feb; 78(2):82-8. PubMed ID: 10023867
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease.
Zoja C; Benigni A; Livio M; Bergamelli A; Orisio S; Abbate M; Bertani T; Remuzzi G
Am J Pathol; 1989 May; 134(5):1027-38. PubMed ID: 2497648
[TBL] [Abstract][Full Text] [Related]
19. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets.
Fitzgerald DJ; Mayo G; Catella F; Entman SS; FitzGerald GA
Am J Obstet Gynecol; 1987 Aug; 157(2):325-30. PubMed ID: 3618681
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
